DLC and 8 national diabetes advocacy partner organizations wrote Congressional Leaders on April 29, 2020, urging them to take action to protect people with diabetes during and after the COVID-19 pandemic. Diabetes advocates stressed the need for affordable insurance, affordable medications and better research to understand and address the impact of COVID-19 on people with diabetes, particularly in communities of color across the United States.Co-signers included the following organizations. Please click the links for more valuable resources on diabetes advocacy and COVID-19:
